Tobam Sells 30,010 Shares of The Clorox Company (NYSE:CLX)

Tobam decreased its stake in The Clorox Company (NYSE:CLX - Free Report) by 27.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,077 shares of the company's stock after selling 30,010 shares during the period. Clorox accounts for approximately 2.4% of Tobam's holdings, making the stock its 9th largest position. Tobam owned approximately 0.06% of Clorox worth $12,882,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. GoalVest Advisory LLC bought a new position in Clorox during the first quarter worth about $31,000. First Foundation Advisors bought a new position in Clorox during the first quarter worth about $31,000. Innealta Capital LLC bought a new position in Clorox during the second quarter worth about $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after purchasing an additional 130 shares during the period. Finally, Quarry LP lifted its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CLX shares. DA Davidson restated a "neutral" rating and set a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and raised their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an "underweight" rating for the company in a research report on Wednesday, July 10th. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $146.13.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.51% of the company's stock.

Clorox Price Performance

CLX traded down $1.46 during trading on Thursday, hitting $158.07. 884,816 shares of the stock traded hands, compared to its average volume of 1,242,800. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09. The company has a market cap of $19.63 billion, a price-to-earnings ratio of 81.70, a PEG ratio of 3.31 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The business has a 50 day moving average price of $156.55 and a 200 day moving average price of $144.65.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Equities research analysts forecast that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.09%. Clorox's dividend payout ratio is currently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.